Strongbridge Biopharma plc.
SBBP
SBBP was delisted on the 5th of October, 2021.
43 hedge funds and large institutions have $158M invested in Strongbridge Biopharma plc. in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
25% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 12
13% more funds holding
Funds holding: 38 → 43 (+5)
2% less capital invested
Capital invested by funds: $161M → $158M (-$2.65M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSC
Lyon Street Capital
Sausalito,
California
|
+$2.86M |
| 2 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$828K |
| 3 |
State Street
Boston,
Massachusetts
|
+$324K |
| 4 |
Millennium Management
New York
|
+$189K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$125K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$573K |
| 2 |
NC
Nexthera Capital
New York
|
-$477K |
| 3 |
Citigroup
New York
|
-$326K |
| 4 |
TAF
Tredje AP-fonden
Se-111 91 Stockholm,
Sweden
|
-$312K |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$258K |
SBBP Hedge Fund Activity: Q3 2017 in Review
43 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Strongbridge Biopharma plc. (SBBP) for Q3 2017, worth a combined $158M — down 1.6% from $161M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new SBBP positions and 3 closed out — a net gain of 5 holders — while 15 added to existing stakes and 12 trimmed.
The largest buyer was Lyon Street Capital, opening a new position worth an estimated $2.86M. The largest seller was Boxer Capital, cutting an estimated $573K.
- 43 institutional investors held Strongbridge Biopharma plc. (SBBP) as of Q3 2017, up from 38 in Q2 2017.
- Funds reported $158M of Strongbridge Biopharma plc. stock for Q3 2017, down 1.6% quarter-over-quarter.
- 8 funds opened new Strongbridge Biopharma plc. positions in Q3 2017 and 3 closed out, a net change of +5 holders.
- The largest Strongbridge Biopharma plc. buyer in Q3 2017 was Lyon Street Capital, an estimated $2.86M added.
- The largest Strongbridge Biopharma plc. seller in Q3 2017 was Boxer Capital, an estimated $573K sold.
Based on aggregated 13F filings for Q3 2017.